Psychedelics Reshape Brain Circuits Through Myelin Remodeling, Study Finds
New research indicates that treatment with psychedelic drugs, such as psilocybin and MDMA, triggers a large-scale reconfiguration of brain network dynamics. This process is driven by the remodeling of myelin, the neuronal insulation layer. The study suggests that enhancing myelination could augment or sustain the therapeutic effects of psychedelic-assisted treatments for Post-traumatic Stress Disorder (PTSD) and related conditions.
Mechanism of Action
While psilocybin and MDMA show rapid clinical effects in PTSD patients, durable benefits require circuit-level stabilization. The study identifies myelin as a link between the short-lived psychedelic experience and the longer-term maintenance of healthier neural network dynamics. Activity-dependent oligodendrogenesis and myelin remodeling may tune disrupted timing and persistent threat responses observed in PTSD by synchronizing brain circuits.
Dr. John Krystal, Editor of Biological Psychiatry, noted that previous research on psychedelics focused on neurons and neuroplasticity, often overlooking the role of other cell types like oligodendrocytes, which produce myelin and contribute to glutamate homeostasis and immune functions.
Experimental Approach
Researchers utilized a rat model of contextual fear conditioning, administering repeated low doses of psilocybin or MDMA. They quantified anxiety-like and exploration behaviors and assessed spatial learning and memory.
The results showed a reduction in anxiety-like behaviors, accompanied by changes in oligodendrocyte biology and genetic signatures indicative of myelin remodeling in the dentate gyrus (part of the hippocampus).
Lead investigator Dr. Mehmet Bostancıklıoğlu explained that the study tested if myelin integrity was required for behavioral change by combining drug interventions with models that either damaged or chemically enhanced brain insulation.
Myelin Repair and Therapeutic Implications
High-powered microscopy and genetic analysis confirmed that both psilocybin and MDMA triggered physical myelin repair. Crucially, blocking the serotonin receptor 5-HT 2A prevented both behavioral and myelin-associated effects. Conversely, blocking fear memory formation with anisomycin reduced anxiety, but myelin remained unrepaired, suggesting biological recovery requires myelin's structural support.
Dr. Bostancıklıoğlu stated that oligodendrocytes and adaptive myelination might function as a testable gate for the durability of psychedelic-associated circuit changes.
Dr. Krystal added that the involvement of oligodendrocytes in therapeutic effects is significant due to their roles in myelin formation, glutamate homeostasis, and neuroinflammation. The findings suggest psychedelics and MDMA may promote recovery from stress-related myelin damage.
The study also identified that psilocybin and MDMA reduce astrocyte reactivity, which can cause inflammation.
Future Outlook and Therapeutic Potential
Investigators suggest that enhancing myelination would not replace psychotherapy but could support the consolidation and maintenance of healthier network communication after an acute psychedelic session.
Dr. Bostancıklıoğlu concluded that myelin-producing cells might be an underappreciated component in translating a transient window of brain plasticity into longer-lasting circuit changes in fear-based models.